Issue: Volume V No. 15 - November 9, 1998

When Managers Make Decisions

IF YOU OPERATE A CLINICAL LABORATORY, does the news of NeoPath, Inc.’s national contracts with Kaiser Permanente and SmithKline Beecham Clinical Laboratories (SBCL) alter your competitive position in the market? After all, it’s only been a few months since the Food and Drug Administration (FDA) approved NeoPath’s Pre-Market Application (PMA) to use its AutoPap System …

When Managers Make Decisions Read More »

Kaiser, SBCL To Automate Pap Smear Screening

CEO SUMMARY: Two of the country’s largest Pap screen testing organizations are preparing to introduce automated primary screening into their laboratories. NeoPath’s con- tracts with SmithKline Beecham Clinical Laboratories and Kaiser Permanente mark the beginning of a new market cycle. NeoPath is poised to exploit these developments while continuing to enhance AutoPap’s capabilities. TWO OF …

Kaiser, SBCL To Automate Pap Smear Screening Read More »

Kaiser Plans Widespread Use For Pap Technology

WITHIN THE HMO INDUSTRY, Kaiser Permanente is highly respected for its thorough research into the clinical efficacy and economic cost of new healthcare technologies. That is the reason why Kaiser’s decision to adopt NeoPath, Inc.’s automated cytology technology for primary screening of Pap smears is getting widespread attention within the laboratory community. Coupled with a similar …

Kaiser Plans Widespread Use For Pap Technology Read More »

SBCL Makes System-Wide Commitment To AutoPap

SOMEONE ALWAYS HAS TO BE FIRST to adopt new technology. In the case of automated cytology, it will be SmithKline Beecham Clinical Laboratories (SBCL). SBCL and NeoPath, Inc. announced a four-year national agreement between the two companies on October 9 which will eventually allow SBCL to process 100% of its annual Pap smear volume using …

SBCL Makes System-Wide Commitment To AutoPap Read More »

PathSOURCE Is Newest Pathology Consolidator

CEO SUMMARY: Based in New York, PathSOURCE becomes the newest pathology network and services company to hit the market. PathSOURCE’s organizers want to link “best in class” dermatopathologists and academic pathology subspecialists to compete for outreach pathology specimens. PathSOURCE is further marketplace evidence that pathologists must innovate or find themselves underutilized. WITH THE GOAL OF …

PathSOURCE Is Newest Pathology Consolidator Read More »

Lab Specialists Acquired By Kroll-O’Gara Company

CEO SUMMARY: Laboratory Specialists of America has demonstrated a multi-year capability to increase revenues and boost earnings. The merger with Kroll-O’Gara provides it with ample capital to intensify its own acquisition program. One key to Laboratory Specialists’ success is its recognition that it is in a service industry, not a test results industry. Client service …

Lab Specialists Acquired By Kroll-O’Gara Company Read More »

Bankruptcy Court Okays Unilab’s Offer For Meris

CEO SUMMARY: Meris Laboratories, Inc. is now history. California’s intense competitive market pushed the company into bankruptcy and eventual sale to Unilab, Inc. Even as Unilab moves to consolidate and integrate Meris’ clients and operations into its system, attention is focusing on BioCypher Laboratories. Observers believe this troubled laboratory may be next on the chopping …

Bankruptcy Court Okays Unilab’s Offer For Meris Read More »

“November 9, 1998 Intelligence: Late Breaking Lab News”

HBO & Co. is the latest to fall victim to consolidation mania. McKesson, Inc. is purchasing HBO for $14 billion in stock. McKesson wants to complement its services as a pharmacy benefits manager with HBO’s extensive health information system capabilities. Combined, the two companies will have more than $21.0 billion in annual revenue. MORE ON:…HBO …

“November 9, 1998 Intelligence: Late Breaking Lab News” Read More »

Powered by Americaneagle.com

Hosted by Americaneagle.com, Inc.